Market Research Logo

Global Radiation Therapy Quality Assurance (QA) Phantoms Market: Focus on Technology, Therapies, Regions, Data – Analysis and Forecast, 2019-2024

Global Radiation Therapy Quality Assurance (QA) Phantoms Market: Focus on Technology, Therapies, Regions, Data – Analysis and Forecast, 2019-2024

Key Questions Answered in this Report:

  • What is the industry structure of the global radiation therapy quality assurance phantoms market?
  • How many patents are currently active in the global radiation therapy quality assurance phantoms market?
  • What are the key development strategies which are implemented by the key players to stand put in the market?
  • How did the radiation therapy quality assurance phantoms market evolve and what is its scope in the future?
  • What are the major market drivers, challenges, and opportunities in the global radiation therapy quality assurance phantoms market?
  • What are the leading companies dominating the global radiation therapy quality assurance phantoms market?
  • What are the key technological advancements in radiation therapy which are expected to impact the growth of phantoms?
  • What are the regulations pertaining to the global radiation therapy quality assurance phantoms market?
  • What was the market value of the leading segments (technologies, therapies, and region) of the global radiation therapy quality assurance phantoms market in 2018?
  • How is each segment of the global radiation therapy quality assurance phantoms market expected to grow during the forecast period and what is the revenue anticipated to be generated by each of the segments by the end of 2024?
  • How is the industry expected to evolve during the forecast period 2019-2024?
  • Which region carries the potential for the significant expansion of key companies for radiation therapy quality assurance phantoms market?
Global Radiation Therapy Quality Assurance Phantoms Market Forecast, 2019-2024

Radiation Therapy Quality Assurance Phantoms Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 4.59% during the forecast period 2019-2024. The radiation therapy quality assurance phantoms market generated $23.13 million revenue in 2018, in terms of value.

The radiation therapy quality assurance phantoms growth has been primarily attributed to the major drivers in this market such as enhanced patient and machine QA in radiation oncology, increasing demand for tissue equivalent phantoms, rise in the burden of cancer, and others. The market is expected to grow at a significant growth rate due to the opportunities that lie within its domain, which include product launches, and increasing partnerships and collaborations with the gamma knife manufacturers and other players in the market ecosystem. However, there are significant challenges which are restraining the market growth. These challenges include high cost of phantoms in the emerging economies, lack of product awareness in the emerging economies, and fierce market competition. Expert Quote
  • The radiation therapy market is looking for solutions which can reduce machine downtime, therapy time while enhancing patient experience and outcome. In such scenario, patient specific phantoms and phantom-less QA processes are expected to be focus area of the market”
  • Scope of the Market Intelligence on Radiation Therapy Quality Assurance Phantoms Market

    The radiation therapy quality assurance phantoms market research provides a holistic view of global market in terms of various factors influencing it, including product launches and technological advancements.

    The scope of this report is centered upon conducting a detailed study of the products used in quality assurance procedures. In addition, the study also includes exhaustive information on impact of radiation therapy quality assurance phantoms on different technologies and therapies, perception on the product launches, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segments, and company, as well as other vital information with respect to global radiation therapy quality assurance phantoms market.

    Market Segmentation

    The radiation therapy quality assurance phantoms market segmentation (based on technology) is further segmented into linear accelerators, Cobalt-60, low-dose radiation, and high-dose radiation.

    The radiation therapy quality assurance phantoms market segmentation (based on therapy) is further segmented into photon beam radiation therapy, stereotactic radiation therapy, advanced 3-D conformal radiation therapy, image guided radiation therapy, volumetric modulated arc therapy, intraoperative radiotherapy, proton beam therapy, neutron beam therapy, and brachytherapy.

    Key Companies in the Global Radiation Therapy Quality Assurance Phantoms Market

    The key manufacturers who have been contributing significantly to the radiation therapy quality assurance phantoms market include Computerized Imaging Reference Systems, Inc., Fluke Biomedical, IBA Dosimetry, Modus Medical Devices Inc., PTW Freiburg GmbH, Standard Imaging Inc., Sun Nuclear Corporation, and The Phantom Laboratory Inc., among others.

    * The single user license comes with a password which can beused only by the designated user to view the file. This format does notallow the user to copy or print the document, or to share the passwordwith anyone other than the user.*


    Executive Summary
    1 Market Definition
    1.1 Radiation Therapy
    1.2 Phantoms
    1.3 Phantoms in Quality Assurance
    2 Scope of the Report
    3 Research Methodology
    3.1 Research Methodology
    3.1.1 Data Triangulation
    3.1.2 Primary Data Sources
    3.1.3 Secondary Data Sources
    3.1.4 Bottom-up Approach
    3.1.5 Assumptions and Limitations
    4 Industry Insights
    4.1 Technological Trends in Radiation Therapy
    4.2 Complete Workflow of Imaging Techniques
    4.2.1 QA Associated with IMRT
    4.2.2 QA Associated with Stereotactic Radiosurgery
    4.3 Regulatory Framework
    4.3.1 Regulatory Framework in the America
    4.3.1.1 Food and Drug Administration (FDA)
    4.3.1.2 United States Department of Health and Human Services (HHS)
    4.3.1.3 The American Society for Radiation Oncology (ASTRO)
    4.3.1.4 American Medical Association (AMA)
    4.3.2 Regulatory Framework in Europe
    4.3.2.1 European Commission (EC)
    4.3.3 Regulatory Framework in Asia-Pacific
    4.4 Patent Analysis
    4.5 Value Chain Analysis
    5 Competitive Landscape
    5.1 Market Share Analysis
    5.2 Key Developments and Strategies
    5.2.1 Collaborations and Partnerships
    5.2.2 Product Launches
    5.2.3 Mergers and Acquisitions
    5.2.4 Business Expansion
    6 Market Dynamics
    6.1 Market Drivers
    6.1.1 Enhanced Patient and Machine Quality Assurance in Radiation Therapy
    6.1.2 Use of Tissue Equivalent Phantoms
    6.1.3 Rising Burden of Cancer
    6.2 Market Challenges/Restraints
    6.2.1 Cost of Phantoms in Emerging Markets
    6.2.2 Increased Market Competition
    6.2.3 Skill Set Gap
    7 Global Radiation Therapy Quality Assurance (QA) Phantoms Market (by Technology)
    7.1 Assumptions and Limitations
    7.2 Overview
    7.3 Linear Accelerators
    7.4 Cobalt-60
    7.5 High-Dose Radiation
    7.6 Low-Dose Radiation
    8 Global Radiation Therapy Quality Assurance (QA) Phantoms Market (by Therapy)
    8.1 Assumptions and Limitations
    8.2 Overview
    8.3 External Radiation Therapy
    8.3.1 Photon Beam Radiation Therapy
    8.3.2 Advanced three-Dimensional Conformal Radiation Therapy (3-D CRT)
    8.3.3 Volumetric Modulated Arc Therapy (VMAT)
    8.3.4 Image Guided Radiation Therapy (IGRT)
    8.3.5 Stereotactic Radiation Therapy
    8.3.6 Intraoperative Radiotherapy (IORT)
    8.3.7 Proton Beam Therapy
    8.3.8 Neutron Beam Therapy
    8.4 Internal Radiation Therapy or Brachytherapy
    9 Global Radiation Therapy Quality Assurance Phantoms Market (by Region)
    9.1 Assumptions and Limitations
    9.2 Overview
    9.2.1 Analysis of Growth Potential of Different Countries
    9.3 North America
    9.3.1 U.S.
    9.3.2 Canada
    9.4 Europe
    9.4.1 Germany
    9.4.2 France
    9.4.3 Russia
    9.4.4 Italy
    9.4.5 U.K.
    9.4.6 Spain
    9.4.7 Rest-of-Europe
    9.5 Asia-Pacific
    9.5.1 China
    9.5.2 Japan
    9.5.3 India
    9.5.4 Australia
    9.5.5 South Korea
    9.5.6 Rest-of-Asia-Pacific
    9.6 Rest-of-the-World
    9.6.1 Latin America
    9.6.1.1 Brazil
    9.6.1.2 Mexico
    9.6.1.3 Rest-of-Latin-America
    9.6.2 Middle East and Africa
    9.6.2.1 Saudi Arabia
    9.6.2.2 Egypt
    9.6.2.3 South Africa
    10 Company Profiles
    10.1 Overview
    10.2 Computerized Imaging Reference Systems, Inc.
    10.2.1 Company Overview
    10.2.2 Role of Computerized Imaging Reference Systems, Inc. in the Global Radiation Therapy QA Phantoms Market
    10.2.2.1 Product Mapping
    10.2.2.2 Recent Developments
    10.2.2.3 Mergers and Acquisitions
    10.2.3 SWOT Analysis
    10.3 Fluke Biomedical
    10.3.1 Company Overview
    10.3.2 Role of Fluke Biomedical in the Global Radiation Therapy QA Phantoms Market
    10.3.2.1 Product Mapping
    10.3.2.2 Recent Developments
    10.3.2.3 Mergers and Acquisitions
    10.3.3 SWOT Analysis
    10.4 IBA Dosimetry
    10.4.1 Company Overview
    10.4.2 Role of IBA Dosimetry in the Global Radiation Therapy QA Phantoms Market
    10.4.2.1 Product Mapping
    10.4.2.2 Recent Developments
    10.4.3 Financials
    10.4.4 SWOT Analysis
    10.5 Modus Medical Devices Inc.
    10.5.1 Company Overview
    10.5.2 Role of Modus Medical Devices Inc. in the Global Radiation Therapy QA Phantoms Market
    10.5.2.1 Product Mapping
    10.5.3 SWOT Analysis
    10.6 PTW Freiburg GmbH
    10.6.1 Company Overview
    10.6.2 Role of PTW Freiburg GmbH in the Global Radiation Therapy QA Phantoms Market
    10.6.2.1 Product Mapping
    10.6.3 SWOT Analysis
    10.7 Standard Imaging Inc.
    10.7.1 Company Overview
    10.7.2 Role of Standard Imaging Inc. in the Global Radiation Therapy QA Phantoms Market
    10.7.2.1 Product Mapping
    10.7.2.2 Recent Developments
    10.7.3 SWOT Analysis
    10.8 Sun Nuclear Corporation
    10.8.1 Company Overview
    10.8.2 Role of Sun Nuclear Corporation in the Global Radiation Therapy QA Phantoms Market
    10.8.2.1 Product Mapping
    10.8.2.2 Recent Developments
    10.8.3 SWOT Analysis
    10.9 The Phantom Laboratory, Inc.
    10.9.1 Company Overview
    10.9.2 Role of The Phantom Laboratory, Inc. in the Global Radiation Therapy QA Phantoms Market
    10.9.2.1 Product Mapping
    10.9.3 SWOT Analysis
    List of Tables
    Table 1: Regional Data for Cancer Patients, Global, 2018
    Table 4.1: Regulatory Authorities/Associations/Consortiums for Medical Devices in Americas
    Table 4.2: Regulatory Authorities/Associations/Consortiums for Medical Devices in Europe
    Table 4.3: Regulatory Authorities/Associations/Consortiums for Medical Devices in Asia-Pacific
    Table 4.4: Patent Analysis for the Global Radiation Therapy Quality Assurance Phantoms Market (by Assignee)
    Table 5.1: Competitors’ Snapshot for the Global Radiation Therapy Quality Assurance Phantoms Market, 2018
    Table 6.1: Planning Process in Radiation Therapy QA
    Table 8.1: Global Radiation Therapy QA Phantoms Market (by Volume: by Therapy), 2019-2024
    Table 10.1: Product Mapping: Computerized Imaging Reference Systems, Inc.
    Table 10.2: Product Mapping: Fluke Biomedical
    Table 10.3: Product Mapping: IBA Dosimetry
    Table 10.4: Product Mapping: Modus Medical Devices Inc.
    Table 10.5: Product Mapping: PTW Freiburg GmbH
    Table 10.6: Product Mapping: Standard Imaging Inc.
    Table 10.7: Product Mapping: Sun Nuclear Corporation
    Table 10.8: Product Mapping: The Phantom Laboratory Inc.
    List of Figures
    Figure 1: Number of New Cancer Cases, Global, 2018
    Figure 2: Impact Analysis of Market Drivers and Challenges
    Figure 3: Global Radiation Therapy Quality Assurance Phantoms Market (by Region), Market Share, 2018
    Figure 4: Radiation Therapy Quality Assurance Phantoms Market, Growth Potential, by Country, 2019-2024
    Figure 5: Global Radiation Therapy QA Phantoms Market (by Region), 2019-2024
    Figure 6: Market Share Analysis for the Global Radiation Therapy Quality Assurance Phantoms Market, 2018
    Figure 2.1: Global Radiation Therapy Quality Assurance Phantoms Market: Segmentation
    Figure 3.1: Radiation Therapy Quality Assurance Phantoms Market Research Methodology
    Figure 3.2: Data Triangulation
    Figure 3.3: Primary Research
    Figure 3.4: Secondary Research
    Figure 3.5: Bottom-Up Approach (Segment-wise Analysis)
    Figure 3.6: Assumptions and Limitations
    Figure 4.1: Value Analysis of Radiation Therapy Quality Assurance Phantom Market
    Figure 5.1: Competitive Landscape- Global Radiation Therapy Quality Assurance Phantoms Market
    Figure 5.2: Market Share Analysis for the Global Radiation Therapy Quality Assurance Phantoms Market, 2018
    Figure 5.3: Share of Key Developments and Strategies, January 2013-September 2019
    Figure 5.4: Collaborations, and Partnerships Share (by Companies), January 2013-September 2019
    Figure 5.5: Product Launches Share (by Companies), January 2013-September 2019
    Figure 5.7: Business Expansion Share (by Companies), January 2013-September 2019
    Figure 6.1: Impact Analysis of Market Drivers and Challenges, 2019-2024
    Figure 6.2: Number of New Cancer Cases (Global), 2018
    Figure 7.1: Global Radiation Therapy Quality Assurance Phantoms Market, by Technology, Market Share, 2018
    Figure 7.2: Global Radiation Therapy Equipment Installations (by Region), 2018
    Figure 7.3: Linear Accelerators in Radiation QA Phantoms Market (by Value), 2019-2024
    Figure 7.4: Linear Accelerators in Radiation QA Phantoms Market (by Volume), 2019-2024
    Figure 7.5: Cobalt-60 in Radiation QA Phantoms Market (by Value), 2019-2024
    Figure 7.6: Cobalt-60 in Radiation QA Phantoms Market (by Volume), 2019-2024
    Figure 7.7: High-Dose Radiation in Radiation QA Phantoms Market (by Value), 2019-2024
    Figure 7.8: High-Dose Radiation in Radiation QA Phantoms Market (by Volume), 2019-2024
    Figure 7.9: Low-Dose Radiation in Radiation QA Phantoms Market (by Value), 2019-2024
    Figure 7.10: Low-Dose Radiation in Radiation QA Phantoms Market (by Volume), 2019-2024
    Figure 8.1: Global Radiation Therapy Quality Assurance Phantoms Market, by Therapy, Market Share, 2018
    Figure 8.2: Global Radiation Therapy Quality Assurance Phantoms Market, by Therapy, Market Share, 2024
    Figure 8.3: Photon Beam Radiation Therapy in Radiation QA Phantoms Market, 2019-2024
    Figure 8.4: Advanced 3D- Conformal Radiation Therapy in Radiation QA Phantoms Market, 2019-2024
    Figure 8.5: Volumetric Modulated Arc Therapy in Global Radiation QA Phantoms Market, 2019-2024
    Figure 8.6: Image-Guided Radiation Therapy in Global Radiation QA Phantoms Market, 2019-2024
    Figure 8.7: Stereotactic Radiation Therapy in Radiation QA Phantoms Market, 2019-2024
    Figure 8.8: Intraoperative Radiotherapy in Global Radiation QA Phantoms Market, 2019-2024
    Figure 8.9: Proton Beam Therapy in Global Radiation QA Phantoms Market, 2019-2024
    Figure 8.10: Neutron Beam Therapy in Global Radiation QA Phantoms Market, 2019-2024
    Figure 8.11: Brachytherapy in Global Radiation QA Phantoms Market, 2019-2024
    Figure 9.1: Global Radiation Therapy Quality Assurance Phantoms Market (by Region), Market Share, 2018
    Figure 9.2: North America: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.3: North America- Market Dynamics
    Figure 9.4: Number of New Cancer Cases in North America, 2018
    Figure 9.5: North America: Number of Phantoms (by Country), 2018-2024
    Figure 9.6: Number of New Cancer Cases in U.S., 2018
    Figure 9.7: U.S.: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.8: Number of New Cancer Cases in Canada, 2018
    Figure 9.9: Canada: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.10: Europe: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.11: Europe: Radiation Therapy Quality Assurance Phantoms, Market Share (by Country), 2018
    Figure 9.12: Europe: Market Dynamics
    Figure 9.13: Number of New Cancer Cases in Europe, 2018
    Figure 9.14: Europe: Number of Phantoms (by Country), 2018-2024
    Figure 9.15: Number of New Cancer Cases in Germany, 2018
    Figure 9.16: Germany: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.17: Number of New Cancer Cases in France, 2018
    Figure 9.18: France: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.19: Number of New Cancer Cases in Russia, 2018
    Figure 9.20: Russia: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.21: Number of New Cancer Cases in Italy, 2018
    Figure 9.22: Italy: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.23: Number of New Cancer Cases in the U.K., 2018
    Figure 9.24: U.K.: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.25: Number of New Cancer Cases in Spain, 2018
    Figure 9.26: Spain: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.27: Rest-of-Europe: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.28: Asia-Pacific: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.29: Asia-Pacific: Number of Phantoms (by Country), 2018-2024
    Figure 9.30: Asia-Pacific: Market Dynamics
    Figure 9.31: Number of New Cancer Cases in Asia, 2018
    Figure 9.32: Number of New Cancer Cases in China, 2018
    Figure 9.33: China: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.34: Number of New Cancer Cases in Japan, 2018
    Figure 9.35: Japan: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.36: Number of New Cancer Cases in India, 2018
    Figure 9.37: India: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.38: Number of New Cancer Cases in Australia, 2018
    Figure 9.39: Australia: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.40: Number of New Cancer Cases in South Korea, 2018
    Figure 9.41: South Korea: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.42: Rest-of-Asia-Pacific: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.43: Rest-of-the-World: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.44: Rest-of-the-World: Number of Phantoms (by Region), 2018-2024
    Figure 9.45: Latin America: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.46: Latin America: Number of Phantoms (by Country), 2018-2024
    Figure 9.47: Number of New Cancer Cases in Brazil, 2018
    Figure 9.48: Brazil: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.49: Number of New Cancer Cases in Mexico, 2018
    Figure 9.50: Mexico: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.51: Rest-of-Latin-America: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.52: Middle East and Africa: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.53: Middle East: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.54: Africa: Radiation Therapy Quality Assurance Phantoms Market, 2019-2024
    Figure 9.55: Number of New Cancer Cases in Saudi Arabia, 2018
    Figure 9.56: Number of New Cancer Cases in Egypt, 2018
    Figure 9.57: Number of New Cancer Cases in South Africa, 2018
    Figure 10.1: Total Number of Companies Profiled
    Figure 10.2: Modality Supported by Phantoms of CIRS, Inc.
    Figure 10.3: Computerized Imaging Reference Systems, Inc.: SWOT Analysis
    Figure 10.4: Modalities Supported by Phantoms of Fluke Biomedical
    Figure 10.5: Fluke Biomedical: SWOT Analysis
    Figure 10.6: Modalities Supported by Phantoms of IBA Dosimetry
    Figure 10.7: IBA Dosimetry: Overall Financials, 2017-2018
    Figure 10.8: IBA Dosimetry: SWOT Analysis
    Figure 10.9: Modalities Supported by Phantoms of Modus Medical Devices Inc.
    Figure 10.10: Modus Medical Devices Inc.: SWOT Analysis
    Figure 10.11: Modalities Supported by Phantoms of PTW Freiburg GmbH
    Figure 10.12: PTW Freiburg GmbH: SWOT Analysis
    Figure 10.13: Modalities Supported by Phantoms of Standard Imaging Inc.
    Figure 10.14: Standard Imaging Inc.: SWOT Analysis
    Figure 10.15: Modalities Supported by Phantoms of Sun Nuclear Corporation
    Figure 10.16: Sun Nuclear Corporation: SWOT Analysis
    Figure 10.17: Modalities Supported by Phantoms of The Phantom Laboratory Inc.
    Figure 10.18: The Phantom Laboratory, Inc.: SWOT Analysis

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook